Your session is about to expire
← Back to Search
Microneedling
Microneedling device for Hyperpigmentation
N/A
Waitlist Available
Research Sponsored by Cynosure, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 day follow up
Awards & highlights
Summary
This trial is testing whether a combination of radiofrequency and microneedling treatments is effective and safe for treating facial aging.
Eligible Conditions
- Wrinkles
- Solar Elastosis
- Hyperpigmentation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 day follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 day follow up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percent of Photos Identified Correctly of 30 Day Follow Up vs. Baseline
Percent of Photos Identified Correctly of 90 Day Follow Up vs. Baseline
Trial Design
1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment2 Interventions
Subjects are to be treated with the RF device, followed by the microneedling device. Parameters may be adjusted throughout the treatment and will determined by the Clinician. Subjects will receive up to 4 treatments, spaced approximately 4 weeks apart.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
RF device
2022
N/A
~50
Microneedling device
2022
N/A
~50
Find a Location
Who is running the clinical trial?
Cynosure, Inc.Lead Sponsor
51 Previous Clinical Trials
1,194 Total Patients Enrolled
Jennifer CiviokStudy DirectorDirector of Clinical Development
16 Previous Clinical Trials
450 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger